# CN Healthy Food Tech Group Corp.: financial statements, quarterly

UCFI · Nasdaq · CIK 1901203 · [Consumer staples](/sectors/consumer-staples.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ucfi.md) · [Financials](/companies/ucfi/financials.md) · [Filings](/companies/ucfi/filings.md) · [Insiders](/companies/ucfi/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/ucfi/financials.md?period=annual).

## Income statement

| Line item | Unit | period not labelled (2023-06-30) | period not labelled (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $k | not reported | not reported | not reported | not reported | not reported | [4,292](/filings/0001213900-25-112657.md) | not reported | [4,823](/filings/0001213900-26-055809.md) | [7,460](/filings/0001213900-26-089578.md) | [7,905](/filings/0001213900-25-112657.md) | [5,829](/filings/0001213900-26-055809.md) | [8,734](/filings/0001213900-26-089578.md) |
| Cost of revenue | $k | not reported | not reported | not reported | not reported | not reported | [1,344](/filings/0001213900-25-112657.md) | not reported | [2,466](/filings/0001213900-26-055809.md) | [2,517](/filings/0001213900-26-089578.md) | [2,338](/filings/0001213900-25-112657.md) | [1,464](/filings/0001213900-26-055809.md) | [2,493](/filings/0001213900-26-089578.md) |
| Gross profit | $k | not reported | not reported | not reported | not reported | not reported | [2,948](/filings/0001213900-25-112657.md) | not reported | [2,357](/filings/0001213900-26-055809.md) | [4,943](/filings/0001213900-26-089578.md) | [5,568](/filings/0001213900-25-112657.md) | [4,365](/filings/0001213900-26-055809.md) | [6,241](/filings/0001213900-26-089578.md) |
| Research and development | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [27.5](/filings/0001213900-26-055809.md) | [30.9](/filings/0001213900-26-089578.md) | [37.8](/filings/0001213900-25-112657.md) | [38.4](/filings/0001213900-26-055809.md) | [35.6](/filings/0001213900-26-089578.md) |
| Operating income | $k | [(60.3)](/filings/0001213900-24-068618.md) | [(137)](/filings/0001213900-24-096270.md) | [(7.0) d](/filings/0001213900-25-015846.md) | [(480)](/filings/0001213900-25-043698.md) | [(238)](/filings/0001213900-25-076067.md) | [2,297](/filings/0001213900-25-112657.md) | [(4,382) d](/filings/0001213900-25-015846.md) | [805](/filings/0001213900-26-055809.md) | [3,874](/filings/0001213900-26-089578.md) | [4,584](/filings/0001213900-25-112657.md) | [731](/filings/0001213900-26-055809.md) | [5,115](/filings/0001213900-26-089578.md) |
| Interest expense | $k | not reported | not reported | not reported | not reported | not reported | [(9.1)](/filings/0001213900-25-112657.md) | not reported | not reported | [5.6](/filings/0001213900-26-089578.md) | [(10.1)](/filings/0001213900-25-112657.md) | [206](/filings/0001213900-26-055809.md) | [130](/filings/0001213900-26-089578.md) |
| Income tax | $k | not reported | not reported | not reported | [211](/filings/0001213900-25-043698.md) | [178](/filings/0001213900-25-076067.md) | [744](/filings/0001213900-25-112657.md) | [(20.3) d](/filings/0001213900-25-015846.md) | [125](/filings/0001213900-26-055809.md) | [1,106](/filings/0001213900-26-089578.md) | [1,378](/filings/0001213900-25-112657.md) | [851](/filings/0001213900-26-055809.md) | [1,506](/filings/0001213900-26-089578.md) |
| Net income | $k | [(60.3)](/filings/0001213900-24-096270.md) | [(137)](/filings/0001213900-24-096270.md) | [(6.8) d](/filings/0001213900-25-015846.md) | [0.4](/filings/0001213900-25-112657.md) | [357](/filings/0001213900-25-112657.md) | [1,567](/filings/0001213900-25-112657.md) | [(548) d](/filings/0001213900-25-015846.md) | [774](/filings/0001213900-26-089578.md) | [2,922](/filings/0001213900-26-089578.md) | [3,345](/filings/0001213900-25-112657.md) | [(309)](/filings/0001213900-26-089578.md) | [3,060](/filings/0001213900-26-089578.md) |
| Diluted EPS | $ per share | not reported | not reported | not reported | not reported | not reported | [0.04](/filings/0001213900-25-112657.md) | not reported | [0.02](/filings/0001213900-26-055809.md) | [0.06](/filings/0001213900-26-089578.md) | [0.07](/filings/0001213900-25-112657.md) | [(0.01)](/filings/0001213900-26-055809.md) | [0.06](/filings/0001213900-26-089578.md) |
| Basic EPS | $ per share | not reported | not reported | not reported | not reported | not reported | [0.04](/filings/0001213900-25-112657.md) | not reported | [0.02](/filings/0001213900-26-055809.md) | [0.06](/filings/0001213900-26-089578.md) | [0.07](/filings/0001213900-25-112657.md) | [(0.01)](/filings/0001213900-26-055809.md) | [0.06](/filings/0001213900-26-089578.md) |

- Revenue: us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | period not labelled (2023-09-30) | FY2023 (2023-12-27) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | period not labelled (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | [2.5](/filings/0001213900-26-089578.md) | [0.2](/filings/0001213900-24-042972.md) | [0.1](/filings/0001213900-24-068618.md) | [0.0](/filings/0001213900-24-096270.md) | [41.4](/filings/0001213900-25-112657.md) | [0.0](/filings/0001213900-25-043698.md) | [0.0](/filings/0001213900-25-076067.md) | [37.2](/filings/0001213900-25-112657.md) | [33.0](/filings/0001213900-26-089578.md) | [29.7](/filings/0001213900-26-055809.md) | [23.3](/filings/0001213900-26-089578.md) |
| Current assets | $m | not reported | [0.7](/filings/0001213900-25-015846.md) | [0.5](/filings/0001213900-24-042972.md) | [0.2](/filings/0001213900-24-068618.md) | [0.1](/filings/0001213900-24-096270.md) | [44.0](/filings/0001213900-25-112657.md) | [0.1](/filings/0001213900-25-043698.md) | [0.2](/filings/0001213900-25-076067.md) | [46.2](/filings/0001213900-25-112657.md) | [36.9](/filings/0001213900-26-089578.md) | [31.4](/filings/0001213900-26-055809.md) | [27.5](/filings/0001213900-26-089578.md) |
| Total assets | $m | not reported | [69.7](/filings/0001213900-25-015846.md) | [70.4](/filings/0001213900-24-042972.md) | [71.0](/filings/0001213900-24-068618.md) | [71.8](/filings/0001213900-24-096270.md) | [50.8](/filings/0001213900-25-112657.md) | [73.6](/filings/0001213900-25-043698.md) | [73.3](/filings/0001213900-25-076067.md) | [56.2](/filings/0001213900-25-112657.md) | [44.7](/filings/0001213900-26-089578.md) | [39.1](/filings/0001213900-26-055809.md) | [35.2](/filings/0001213900-26-089578.md) |
| Current liabilities | $m | not reported | [0.9](/filings/0001213900-25-015846.md) | [1.1](/filings/0001213900-24-042972.md) | [1.2](/filings/0001213900-24-068618.md) | [1.5](/filings/0001213900-24-096270.md) | [39.9](/filings/0001213900-25-112657.md) | [3.4](/filings/0001213900-25-043698.md) | [72.4](/filings/0001213900-25-076067.md) | [38.2](/filings/0001213900-25-112657.md) | [24.6](/filings/0001213900-26-089578.md) | [19.0](/filings/0001213900-26-055809.md) | [11.7](/filings/0001213900-26-089578.md) |
| Total liabilities | $m | not reported | [3.4](/filings/0001213900-25-015846.md) | [3.6](/filings/0001213900-24-042972.md) | [3.7](/filings/0001213900-24-068618.md) | [4.0](/filings/0001213900-24-096270.md) | [39.9](/filings/0001213900-25-112657.md) | [5.9](/filings/0001213900-25-043698.md) | [75.0](/filings/0001213900-25-076067.md) | [38.5](/filings/0001213900-25-112657.md) | [24.9](/filings/0001213900-26-089578.md) | [19.2](/filings/0001213900-26-055809.md) | [11.9](/filings/0001213900-26-089578.md) |
| Shareholders' equity | $m | [(0.5)](/filings/0001213900-24-096270.md) | [0.0](/filings/0001213900-25-112657.md) | [6.9](/filings/0001213900-25-112657.md) | [7.3](/filings/0001213900-25-112657.md) | [9.1](/filings/0001213900-25-112657.md) | [10.8](/filings/0001213900-26-089578.md) | [11.6](/filings/0001213900-26-089578.md) | [14.7](/filings/0001213900-26-089578.md) | [17.7](/filings/0001213900-25-112657.md) | [19.9](/filings/0001213900-26-089578.md) | [19.9](/filings/0001213900-26-089578.md) | [23.3](/filings/0001213900-26-089578.md) |

- Cash and equivalents: us-gaap:Cash, us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(0.4)](/filings/0001213900-25-043698.md) | [(0.1) d](/filings/0001213900-25-076067.md) | [22.3 d](/filings/0001213900-25-112657.md) | [(22.9) d](/filings/0001213900-25-015846.md) | [(0.2)](/filings/0001213900-26-055809.md) | [(1.3) d](/filings/0001213900-26-089578.md) | [(4.2) d](/filings/0001213900-25-112657.md) | [(3.6)](/filings/0001213900-26-055809.md) | [(7.0) d](/filings/0001213900-26-089578.md) |
| Capital expenditure | $m | not reported | not reported | not reported | not reported | [0.1](/filings/0001213900-26-055809.md) | [0.2 d](/filings/0001213900-26-089578.md) | [0.2 d](/filings/0001213900-25-112657.md) | [0.0](/filings/0001213900-26-055809.md) | [0.0 d](/filings/0001213900-26-089578.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [47.7](/filings/0001213900-25-112657.md) | [47.7](/filings/0001213900-26-055809.md) | [47.7](/filings/0001213900-26-089578.md) | [47.7](/filings/0001213900-25-112657.md) | [52.2](/filings/0001213900-26-055809.md) | [52.2](/filings/0001213900-26-089578.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 52,234,983 at 2026-08-14, from the cover of the [10-Q filed 2026-08-14](/filings/0001213900-26-089578.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:49 ET. No prices; not investment advice.